SB
IART icon

Suntrust Banks’s Integra LifeSciences IART Stock Holding History

Suntrust Banks’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,088
Closed -$432K – 1359
2016
Q4 		$432K Buy
10,088
+2,016
+25% +$81.9K ﹤0.01% 1064
2016
Q3 		$333K Sell
8,072
-1,444
-15% -$60.5K ﹤0.01% 1150
2016
Q2 		$379K Buy
9,516
+40
+0.4% +$1.44K ﹤0.01% 1060
2016
Q1 		$318K Sell
9,476
-418
-4% -$13K ﹤0.01% 1105
2015
Q4 		$334K Buy
+9,894
New +$309K ﹤0.01% 1082

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Suntrust Banks's IART Position: Q1 2017 in Review

Suntrust Banks sold out of Integra LifeSciences (IART) in Q1 2017, closing a stake of 10,088 shares — an estimated $432K sold.

Suntrust Banks first reported a position in IART in Q4 2015 and held it in 5 quarters. The position peaked at $432K in Q4 2016. 236 funds tracked by Wall St. Rank hold IART as of Q1 2017.

  • Suntrust Banks reported no remaining Integra LifeSciences position as of Q1 2017 after selling out during the quarter.
  • Suntrust Banks sold 10,088 Integra LifeSciences shares in Q1 2017, an estimated $432K.
  • Suntrust Banks first reported a position in Integra LifeSciences in Q4 2015 and held it in 5 quarters.
  • Suntrust Banks's Integra LifeSciences position peaked at $432K in Q4 2016.
  • 236 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2017.

Based on Suntrust Banks's 13F filing for Q1 2017, filed 3 May 2017.